Logo image of STAA

STAAR SURGICAL CO (STAA) Stock Fundamental Analysis

NASDAQ:STAA - US8523123052 - Common Stock

27.46 USD
-0.01 (-0.04%)
Last: 8/27/2025, 10:43:31 AM
Fundamental Rating

4

Taking everything into account, STAA scores 4 out of 10 in our fundamental rating. STAA was compared to 185 industry peers in the Health Care Equipment & Supplies industry. STAA has a great financial health rating, but its profitability evaluates not so good. STAA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year STAA has reported negative net income.
In the past year STAA has reported a negative cash flow from operations.
STAA had positive earnings in 4 of the past 5 years.
In the past 5 years STAA always reported a positive cash flow from operatings.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

STAA has a Return On Assets (-21.76%) which is comparable to the rest of the industry.
STAA has a Return On Equity (-28.31%) which is in line with its industry peers.
Industry RankSector Rank
ROA -21.76%
ROE -28.31%
ROIC N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

STAA has a better Gross Margin (71.70%) than 82.70% of its industry peers.
In the last couple of years the Gross Margin of STAA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for STAA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
STAA has more shares outstanding than it did 1 year ago.
STAA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for STAA has been reduced compared to a year ago.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

STAA has an Altman-Z score of 8.10. This indicates that STAA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.10, STAA belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.1
ROIC/WACCN/A
WACC8.92%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.94 indicates that STAA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.94, STAA is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
STAA has a Quick Ratio of 4.05. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
STAA has a Quick ratio of 4.05. This is in the better half of the industry: STAA outperforms 75.14% of its industry peers.
Industry RankSector Rank
Current Ratio 4.94
Quick Ratio 4.05
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

STAA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -212.50%.
STAA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.49% yearly.
The Revenue for STAA has decreased by -32.59% in the past year. This is quite bad
Measured over the past years, STAA shows a quite strong growth in Revenue. The Revenue has been growing by 15.88% on average per year.
EPS 1Y (TTM)-212.5%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-194.44%
Revenue 1Y (TTM)-32.59%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-55.23%

3.2 Future

The Earnings Per Share is expected to grow by 22.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.19% on average over the next years.
EPS Next Y-574.76%
EPS Next 2Y-58.08%
EPS Next 3Y3.43%
EPS Next 5Y22.71%
Revenue Next Year-24.74%
Revenue Next 2Y-2.01%
Revenue Next 3Y1.82%
Revenue Next 5Y5.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STAA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STAA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.08%
EPS Next 3Y3.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for STAA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STAAR SURGICAL CO

NASDAQ:STAA (8/27/2025, 10:43:31 AM)

27.46

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners107.51%
Inst Owner Change2.83%
Ins Owners0.38%
Ins Owner Change15.59%
Market Cap1.35B
Analysts71.58
Price Target25.12 (-8.52%)
Short Float %13.09%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.1%
Min EPS beat(2)12.63%
Max EPS beat(2)49.58%
EPS beat(4)3
Avg EPS beat(4)-804.03%
Min EPS beat(4)-3398.76%
Max EPS beat(4)120.44%
EPS beat(8)6
Avg EPS beat(8)-381.38%
EPS beat(12)9
Avg EPS beat(12)-234.3%
EPS beat(16)12
Avg EPS beat(16)-163.13%
Revenue beat(2)2
Avg Revenue beat(2)5.93%
Min Revenue beat(2)3.61%
Max Revenue beat(2)8.25%
Revenue beat(4)2
Avg Revenue beat(4)-6.53%
Min Revenue beat(4)-37.91%
Max Revenue beat(4)8.25%
Revenue beat(8)4
Avg Revenue beat(8)-3.38%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)6
Avg Revenue beat(16)-1.67%
PT rev (1m)28.93%
PT rev (3m)13.99%
EPS NQ rev (1m)36.92%
EPS NQ rev (3m)-45.83%
EPS NY rev (1m)11.15%
EPS NY rev (3m)6.2%
Revenue NQ rev (1m)4.19%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)0.93%
Revenue NY rev (3m)-0.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.02
P/FCF N/A
P/OCF N/A
P/B 4.01
P/tB 4.03
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS4.56
BVpS6.84
TBVpS6.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.76%
ROE -28.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.7%
FCFM N/A
ROA(3y)3.25%
ROA(5y)3.83%
ROE(3y)4.04%
ROE(5y)4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y0.47%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 180.2%
Cap/Sales 6.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.94
Quick Ratio 4.05
Altman-Z 8.1
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)365.33%
Cap/Depr(5y)348.39%
Cap/Sales(3y)6.49%
Cap/Sales(5y)6.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.5%
EPS 3Y-12.35%
EPS 5Y7.49%
EPS Q2Q%-194.44%
EPS Next Y-574.76%
EPS Next 2Y-58.08%
EPS Next 3Y3.43%
EPS Next 5Y22.71%
Revenue 1Y (TTM)-32.59%
Revenue growth 3Y10.84%
Revenue growth 5Y15.88%
Sales Q2Q%-55.23%
Revenue Next Year-24.74%
Revenue Next 2Y-2.01%
Revenue Next 3Y1.82%
Revenue Next 5Y5.19%
EBIT growth 1Y-410.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-532.21%
EBIT Next 3Y79.25%
EBIT Next 5Y67.76%
FCF growth 1Y-8000.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-281.92%
OCF growth 3Y-29.01%
OCF growth 5Y-9.43%